Simon Stern

999 total citations
25 papers, 536 citations indexed

About

Simon Stern is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Simon Stern has authored 25 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 10 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Simon Stern's work include Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Simon Stern is often cited by papers focused on Multiple Myeloma Research and Treatments (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Simon Stern collaborates with scholars based in United Kingdom, Canada and Netherlands. Simon Stern's co-authors include Gordon Sussman, Jacques Hébert, Carly C. Barron, David Armstrong, Lawrence A. Lavery, Lawrence B. Harkless, Sally F. Barrington, Tim Illidge, Kate Cwynarski and Kim Linton and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Simon Stern

20 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Stern United Kingdom 10 213 168 154 148 83 25 536
Gesina Hansel Germany 12 100 0.5× 149 0.9× 131 0.9× 22 0.1× 24 0.3× 49 543
Julien Henry France 12 55 0.3× 37 0.2× 121 0.8× 41 0.3× 28 0.3× 30 451
Zafer Başlar Türkiye 13 119 0.6× 120 0.7× 70 0.5× 182 1.2× 307 3.7× 82 578
Tomohiro Kameda Japan 14 121 0.6× 77 0.5× 191 1.2× 107 0.7× 40 0.5× 64 547
Xuerong Deng China 13 40 0.2× 54 0.3× 326 2.1× 26 0.2× 90 1.1× 42 511
Pablo Bertín Chile 10 143 0.7× 52 0.3× 86 0.6× 195 1.3× 107 1.3× 39 440
Jonathan London France 14 113 0.5× 17 0.1× 144 0.9× 45 0.3× 26 0.3× 43 522
Naoto Yokogawa Japan 14 85 0.4× 22 0.1× 314 2.0× 100 0.7× 35 0.4× 70 603
Nodoka Sekiguchi Japan 12 94 0.4× 117 0.7× 33 0.2× 79 0.5× 40 0.5× 51 407
G. Fraile Spain 11 109 0.5× 51 0.3× 108 0.7× 37 0.3× 33 0.4× 26 403

Countries citing papers authored by Simon Stern

Since Specialization
Citations

This map shows the geographic impact of Simon Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Stern more than expected).

Fields of papers citing papers by Simon Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Stern. The network helps show where Simon Stern may publish in the future.

Co-authorship network of co-authors of Simon Stern

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Stern. A scholar is included among the top collaborators of Simon Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Stern. Simon Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messiou, Christina, Núria Porta, Dow‐Mu Koh, et al.. (2025). Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma. Blood Cancer Journal. 15(1). 122–122.
2.
Jenner, Matthew, et al.. (2025). Management of relapsed multiple myeloma: A British Society of Haematology and UK Myeloma Society guideline. British Journal of Haematology. 207(6). 2322–2354.
3.
Yong, Kwee, Karthik Ramasamy, Simon Stern, et al.. (2024). Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 204(4). 1193–1206. 1 indexed citations
4.
Kaiser, Martin, Guy Pratt, Ceri Bygrave, et al.. (2024). Diagnosis and initial treatment of transplant‐eligible high‐risk myeloma patients: A British Society for Haematology/UK Myeloma Society Good Practice Paper. British Journal of Haematology. 205(3). 833–839. 3 indexed citations
5.
Kaiser, Martin, Vicky Goh, Simon Stern, et al.. (2024). Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper. British Journal of Haematology. 205(4). 1319–1325. 3 indexed citations
6.
7.
Stern, Simon, et al.. (2023). Investigation and management of the monoclonal gammopathy of undetermined significance. British Journal of Haematology. 202(4). 734–744. 4 indexed citations
8.
Gibson, Scott, Lucy A. Eddowes, Mark T. Drayson, et al.. (2023). An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom. Value in Health Regional Issues. 35. 27–33.
9.
Bird, Sarah, Robyn Shea, Radovan Sašo, et al.. (2021). Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma. The Lancet Haematology. 8(6). e389–e392. 75 indexed citations
10.
Messiou, Christina, Núria Porta, Bhupinder Sharma, et al.. (2021). Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma. Radiology Imaging Cancer. 3(5). e210048–e210048. 38 indexed citations
11.
Bird, Sarah, Robyn Shea, Radovan Sašo, et al.. (2021). P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy. Clinical Lymphoma Myeloma & Leukemia. 21. S114–S114. 2 indexed citations
12.
Cwynarski, Kate, Maria A. V. Marzolini, Sally F. Barrington, et al.. (2019). The management of primary mediastinal B‐cell lymphoma: a British Society for Haematology Good Practice Paper. British Journal of Haematology. 185(3). 402–409. 16 indexed citations
13.
Chaganti, Sridhar, Tim Illidge, Sally F. Barrington, et al.. (2016). Guidelines for the management of diffuse large B‐cell lymphoma. British Journal of Haematology. 174(1). 43–56. 113 indexed citations
14.
Sussman, Gordon, et al.. (2014). Real-life experiences with omalizumab for the treatment of chronic urticaria. Annals of Allergy Asthma & Immunology. 112(2). 170–174. 114 indexed citations
15.
Song, Christine, et al.. (2012). Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria. Annals of Allergy Asthma & Immunology. 110(2). 113–117. 46 indexed citations
16.
Stern, Simon, et al.. (2008). Prolonged thrombocytopenia following alpha-interferon for refractory immune thromobocytopenic purpura. Clinical & Laboratory Haematology. 16(2). 183–185.
17.
Nikapota, Ashok & Simon Stern. (2002). Bruising in a man with aortic aneurysms. Journal of the Royal Society of Medicine. 95(11). 556–557. 1 indexed citations
18.
Bower, Mark, Simon Stern, Kathryn Fife, Mark Nelson, & Brian Gazzard. (2000). Weekly alternating combination chemotherapy for good prognosis AIDS-related lymphoma. European Journal of Cancer. 36(3). 363–367. 17 indexed citations
19.
Samson, D, Gail Abrahamson, JF Apperley, et al.. (1998). High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels. British Journal of Cancer. 78(7). 928–932. 19 indexed citations
20.
Armstrong, David, Lawrence A. Lavery, Simon Stern, & Lawrence B. Harkless. (1996). Is prophylactic diabetic foot surgery dangerous?. The Journal of Foot & Ankle Surgery. 35(6). 585–589. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gesina Hansel Breakdown of academic impact, for papers by Julien Henry Breakdown of academic impact, for papers by Zafer Başlar Breakdown of academic impact, for papers by Tomohiro Kameda Breakdown of academic impact, for papers by Xuerong Deng Breakdown of academic impact, for papers by Pablo Bertín Breakdown of academic impact, for papers by Jonathan London Breakdown of academic impact, for papers by Naoto Yokogawa Breakdown of academic impact, for papers by Nodoka Sekiguchi Breakdown of academic impact, for papers by G. Fraile
Rankless by CCL
2026